NorthStar Health Network
Clinical AI Governance Assessment
A simulated AI governance engagement for a regional hospital system using AI across clinical care, patient communication, operational planning, revenue-cycle management, and internal workforce tools.
The assessment evaluates NorthStar Health Network’s clinical AI inventory, patient-safety risks, human oversight, health-data governance, vendor controls, model monitoring, incident response, and executive decision-making.
The objective is to establish a governance structure that allows the health system to adopt AI while protecting patient safety, clinical judgment, privacy, equity, and accountability.
Focus: Clinical AI Governance · Patient Safety · Human Oversight · Health Data Privacy · Vendor Risk · Model Monitoring · Executive Accountability
The Governance Challenge
AI is becoming embedded across hospital operations and clinical workflows, including patient-risk identification, diagnostic prioritization, clinical documentation, patient communication, capacity planning, revenue-cycle activities, and workforce support.
These systems can improve efficiency and decision support, but they also introduce material governance obligations because errors may affect patient safety, clinical outcomes, privacy, access to care, and organizational accountability.
Effective governance therefore requires NorthStar Health Network to maintain clear visibility into:
-
Which AI systems are deployed across the organization
-
Which systems influence diagnosis, treatment, prioritization, or patient access
-
Which patient populations may be disproportionately affected by model limitations or performance gaps
-
Whether models have been validated for NorthStar’s clinical environment and patient population
-
Whether clinicians understand intended use, limitations, and appropriate reliance on AI outputs
-
How disagreements between clinical judgment and AI recommendations are managed
-
How performance and outcomes are evaluated across patient groups
-
How protected health information and other sensitive data are collected, accessed, retained, and shared
-
How third-party model updates and material system changes are governed
-
What thresholds require investigation, suspension, rollback, or executive escalation
-
Who holds authority to approve, restrict, or discontinue an AI system
Clinical AI governance must therefore extend beyond technology approval.
It requires an integrated operating model connecting:
Patient Safety · Clinical Governance · Privacy · Security · Data Governance · Vendor Oversight · Performance Monitoring · Incident Management
Clinical AI Governance Artifacts
01 | Clinical AI Inventory & Risk Heat Map
Creates an authoritative register of AI-enabled systems operating across NorthStar Health Network. Representative systems include:
Sepsis Prediction Model
Radiology Prioritization AI
Patient Portal Chatbot
Clinical Note Summarizer
Bed Allocation Predicto
rRevenue Cycle AI
Employee Generative AI Assistant
Each system is documented by:
Clinical or operational purposeBusiness and clinical owner
VendorAI or model typ
ePatient populationData used
Decision influenceHuman oversight
Risk tierValidation status
Deployment status
Monitoring requirements
A risk heat map highlights where the most consequential AI systems sit across the health network.
Demonstrates: AI Discovery · Clinical Risk Visibility · System Ownership · Enterprise Inventory
02 | Clinical AI Risk Classification Standard
Establishes a consistent method for determining the level of governance required for each AI system.
Risk factors include:
Patient-safety impact
Clinical decision influence
Level of automation
Potential for delayed or inappropriate care
Protected health information
Vulnerable populations
Bias and health-equity risk
Explainability
Human override availability
Vendor transparency
Scale of deployment
Regulatory exposure
Systems that influence diagnosis, treatment, clinical prioritization, or serious patient outcomes receive the strongest governance requirements.
Demonstrates: Risk Tiering · Patient-Safety Classification · Proportional Governance · Approval Controls
Applied Case Study
Sepsis Prediction Model
Early Identification of Clinical Deterioration
The centerpiece of the engagement is a simulated AI-enabled sepsis prediction model designed to identify hospitalized patients who may be at increased risk of deterioration.
Because missed alerts, inaccurate predictions, poor workflow integration, or overreliance on the model could contribute to significant patient harm, the system is treated as a high-impact clinical AI application.
03 | Sepsis Prediction Algorithmic Impact Assessment
Evaluates the sepsis model before broader deployment.
The assessment examines:
Intended clinical purpose
Patient population
Clinical workflow
Data sources
Model outputs
Decision influence
Known limitations
Patient-safety risks
Health-equity considerations
False-positive riskFalse-negative riskAlert fatigue
Human oversight
Clinical escalation
Vendor dependency
Monitoring requirements
Residual risk
The assessment asks not only whether the model predicts sepsis accurately, but whether NorthStar can deploy it safely within real clinical workflows.
The governance recommendation is:
Conditional GO for controlled pilot deployment.NO-GO for system-wide expansion until identified safety and validation conditions are resolved.
Demonstrates: Algorithmic Impact Assessment · Clinical AI Risk · Patient Safety · Deployment Decision
04 | Patient Safety Hazard Analysis
Identifies how AI-related failures could translate into patient harm.The hazard analysis examines scenarios including:
Missed sepsis risk
False alerts
Alert fatigue
Delayed clinician response
Poor data quality
Incorrect patient mapping
Automation bias
Workflow failureVendor outage
Model drift
Performance differences across patient populations
For each hazard, the assessment identifies:
Potential harm Likelihood
Severity
Existing controls
Additional mitigation
Accountable owner
Residual risk
Escalation threshold
This connects AI governance directly to established patient-safety thinking rather than treating AI risk as purely technical.
Demonstrates: Patient Safety · Hazard Analysis · Clinical Risk Management · Mitigation
05 | Human Oversight & Clinical Escalation Procedure
Defines how clinicians remain responsible for patient-care decisions when AI is involved.
The procedure establishes:
What the AI system may recommend
What the system may never decide independently
Clinician review requirements
Override authority
Escalation pathways
Documentation requirements
No-automation thresholds
Response expectations for critical alerts
Disagreement between clinical judgment and model output
When an AI system should be paused
Human oversight is treated as an active clinical control, not simply the presence of a person somewhere in the process.
Demonstrates: Meaningful Human Oversight · Clinical Judgment · Override Authority · Escalation
06 | Health Data, Privacy & Vendor Governance Assessment
Evaluates how patient and clinical information is used across NorthStar’s AI ecosystem.
The assessment examines:
Protected health information
Data minimization
Permitted data useTraining-data restrictions
Secondary use
Retention
Deletion
Access controls
Vendor access
Subprocessors
Security safeguards
Model improvement clauses
Incident notification
Vendor model changes
Audit rights
Exit planning
The goal is to ensure that access to sensitive health information is limited to what is necessary for the approved clinical or operational purpose
.Demonstrates: Health Data Governance · Privacy · Vendor Risk · Third-Party AI Controls
07 | Clinical AI Monitoring & Model Performance Plan
Extends governance beyond initial validation and approval.
The monitoring program tracks:
Model sensitivity
Specificity
False-positive rates
False-negative rates
CalibrationAlert volume
Clinician override rates
Time to clinical response
Data-quality issues
Performance drift
Patient-safety events
Performance across patient subgroups
User complaints
Vendor model changes
Threshold breaches trigger:
Investigation
Enhanced monitoring
Clinical review
Model recalibration
Revalidation
Workflow changes
Temporary suspension
Rollback
Executive escalation
A clinical AI system remains approved only while evidence demonstrates that it continues to operate safely.
Demonstrates: Continuous Monitoring · Model Drift · Safety Metrics · Performance Governance
08 | Controls & Evidence Matrix
Translates AI risks into operational controls and auditable proof.
For every major risk, the matrix records:
RiskControl objective
Preventive or detective contro
lControl owner
Required evidence
Testing method
Testing frequency
Control status
Known gaps
Residual risk
Examples of evidence include:
Model documentation and version history
Data lineage recordsValidation reports
Fairness testing
Consumer-notice samples
Vendor contracts
Access logs
Monitoring dashboards
Committee approvals
Incident records
The matrix demonstrates that governance requirements exist not only on paper, but as testable controls supported by evidence.
Demonstrates: Control Design · Auditability · Evidence Management · Accountability